The researchers analyzed data from previously untreated adult patients with low- or intermediate-risk MDS. A retrospective study showed that response rate and survival outcome are still modest for high-risk patients. Of 23 patients, three achieved complete remission and 15 achieved complete remission with incomplete hematological recovery.